What's breaking now, across thousands of outlets.
KUALA LUMPUR, Sept 17 (Bernama) -- QurCan Therapeutics (QurCan), a Toronto-based biotechnology company, has announced an exclusive research and collaboration agreement with Eli Lilly and Company (Lilly) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS).
We haven't written up this one. Bernama has the full story — the link below goes straight to it.
LAHORE: The Punjab government has obtained an undertaking on a 13-point proforma before issuing notifications of newly-appointed vice chancellors of five public sector medical universities for the…
A life-extending drug will be made available on the NHS to patients in England with a specific type of incurable breast cancer, after an initial decision to reject the treatment was reversed.
A life-extending drug will be made available on the NHS to patients in England with a specific type of incurable breast cancer, after an initial decision to reject the treatment was reversed.
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
A new survey finds that one third of insured Americans are paying off medical bills.
